Good afternoon :)
Switch to
Place Order

Dr. Lal PathLabs Ltd

LALPATHLAB
Health CareHospitals & Diagnostic Centres
MidcapWith a market cap of ₹29,389 cr, stock is ranked 169
Moderate RiskStock is 2.43x as volatile as Nifty
3,515.4541.00 (-1.15%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHospitals & Diagnostic Centres
MidcapWith a market cap of ₹29,389 cr, stock is ranked 169
Moderate RiskStock is 2.43x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
100.78
PB RatioPB Ratio
23.03
Dividend YieldDiv. Yield
0.57%
Sector PESector PE
38.48
Sector PBSector PB
5.13
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

18%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.

Brands

Dr. Lal PathLabs

Diagnostic and healthcare services by Dr. Lal PathLabs Ltd

Investor PresentationView older 

Oct 26, 2021

PDF
View Older Presentations

Brands

Dr. Lal PathLabs

Diagnostic and healthcare services by Dr. Lal PathLabs Ltd

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

20182019202020211.091.251.391.630.170.200.230.29
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.23%

See detailed holdings

Recent EventsAll events 

Investor Presentation 
Announced OnOct 26, 2021

Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation | Download

Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation | Download

Press Release 
Announced OnOct 26, 2021

Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated October 26, 2021, titled "Press Release for Unaudited Financial Results (Standalone and Consolidated)for the Quarter and Half Year ended September 30, 2021". | Download

Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated October 26, 2021, titled "Press Release for Unaudited Financial Results (Standalone and Consolidated)for the Quarter and Half Year ended September 30, 2021". | Download

Cash Dividend 
Ex. DateAug 18, 2021

Interim • Div/Share: ₹ 6

See all events